alexa

GET THE APP

Jakub Tolar | OMICS International

Journal of Oncology Research and Treatment
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Jakub Tolar

USA
Publications

Tissue-Specific Differences in Mesenchymal Stromal Cells Influence Homing and Function

Mesenchymal Stromal Cell(MSC) therapies to modulate inflammation and promote tissue regeneration in Recessive Dystrophic Epidermolysis Bullosa(RDEB) are under active investigation in clinical trials. However, optimal tissue source and fundamental mechanisms of clinical benefit of MSCs require additional investigation. Riedl et al.recently published... Read More»

Christen L. Ebens, Julia A. Riedl and Jakub Tolar

: J Oncol Res Treat

10.4172/aot.s1.1000001

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top